ADMINISTRATION SET,

The contract specifies the procurement of a pediatric scalp vein administration set with a 21 gauge by 0.75 inch needle, no end cap, individually packaged, sterile, and disposable, supplied in units of 200 per package. Each unit must have a minimum shelf life of 36 months, with no more than four months having elapsed from the date of manufacture to the date of delivery to the government. The product is regulated by the FDA and must be sourced from either Kawasumi Laboratories America or Cardinal Health, both under part number DBMS-21G, and bidders are required to clearly state their source and part number. Packaging must comply with commercial standards as outlined in the procurement document, with each unit sealed in a container that protects against damage or breakage, and all shipments must be in suitable exterior packaging to ensure safe and cost-effective delivery via common carriers to the designated destination. Marking requirements are governed by Medical Marking Standard No. 1, which supersedes MIL-STD-129, and each container must include the lot number and date of manufacture labeled with the prefix “MFD.” The delivery is FOB destination, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The required delivery date is May 8, 2026, with a 20-day delivery window, and the items are destined for APO AE 09094-3219 and Ramstein, Germany. All packaging, marking, and logistics must align with DLA procedures and technical requirements as defined in the DLA Master List of Technical and Quality Requirements.